Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine Alone in Treatment of Favorable, Limited-Stage Hodgkin's Lymphoma: Do We Really Have Robust Data?


Basaran G., Agaoglu F. , Basaran M.

JOURNAL OF CLINICAL ONCOLOGY, cilt.28, 2010 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 28 Konu: 27
  • Basım Tarihi: 2010
  • Doi Numarası: 10.1200/jco.2010.29.0304
  • Dergi Adı: JOURNAL OF CLINICAL ONCOLOGY